|
Form Serial Number: |
DA20190703E00051
|
1.
Date of relevant event: |
27/06/2019 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
01345 |
4.
Name of listed corporation: |
China Pioneer Pharma Holdings Ltd. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
1,263,308,000 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Li |
(Other names) |
Xinzhou |
|
|
|
10.
Name of director (Chinese): |
李新洲 |
11.
Chinese Character Code as printed on HKID Card: |
262124503166 |
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1310 | There has been a change in nature of your interest in the shares because: you are a beneficiary under a trust and the shares have been transferred to you by a trustee | |
2307 | Founder of a discretionary trust who can influence how the trustee exercises his discretion | |
2201 | Interest of corporation controlled by you | |
858,392,000 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 894,509,000 | 70.81 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 894,509,000 | 70.81 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
2201 | Interest of corporation controlled by you |
| |
2202 | Interest of your spouse |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
Spouse | Wu Qian | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Tian Tian Limited | Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands | Li Xinzhou | 50.00 | N | |
Pioneer Pharma (BVI) Co., Ltd. | 171 Main Street, Road Town, Tortola VG1110, British Virgin Islands | Tian Tian Limited | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
50% of the total share capital in Tian Tian Limited which indirectly holds 858,392,000 shares of China Pioneer Pharma Holdings Ltd., had been transferred to me from UBS Trustees (BVI) Limited by way of trust distribution.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
03/07/2019 (dd/mm/yyyy)
|
|